Landmark Bioventures

Landmark BioVentures and G.CLIPS Biotech forge strategic alliance to address critical gaps in drug target engagement 

Partnership brings into sharper focus need to integrate target engagement and candidate profiling solutions to optimize drug development process and increase likelihood of success23 April 2025 -- Basel, Switzerland, and Toulouse, France -- Landmark BioVentures (LBV), an integrative corporate and drug development company using resources smartly to advance multiple innovative therapies, and G.CLIPS Biotech, a technology platform...
Bernouillistrasse 20 Basel CH-4056 Switzerland